Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Werewolf Therapeutics (HOWL) Non Operating Income (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Non Operating Income for 5 consecutive years, with -$324000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 78.63% to -$324000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.5 million through Dec 2025, down 199.27% year-over-year, with the annual reading at -$145000.0 for FY2025, 108.98% down from the prior year.
  • Non Operating Income for Q4 2025 was -$324000.0 at Werewolf Therapeutics, up from -$644000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $1.6 million in Q2 2024, with the low at -$1.5 million in Q4 2024.
  • Average Non Operating Income over 5 years is -$27950.0, with a median of -$11000.0 recorded in 2021.
  • Peak annual rise in Non Operating Income hit 9120.0% in 2024, while the deepest fall reached 25166.67% in 2024.
  • Over 5 years, Non Operating Income stood at $153000.0 in 2021, then plummeted by 54.25% to $70000.0 in 2022, then tumbled by 108.57% to -$6000.0 in 2023, then crashed by 25166.67% to -$1.5 million in 2024, then surged by 78.63% to -$324000.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$324000.0, -$644000.0, and -$440000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.